October 7, 2024 BERLIN, Germany — Dopavision presented its six-month clinical trial data from its MyopiaX-1 trial at the 2024 International Myopia...
July 23, 2024 NovaSight, an Israeli Health-Tech company focusing on eye-tracking-based vision care solutions, is developing TrackSight, a software-as-a-service (SaaS) solution for...
May 28, 2024 BERLIN, Germany — Dopavision has announced early findings from its clinical trial for MyopiaX-1. The six-month outcomes of the...
October 27, 2023 SALT LAKE CITY — iVeena Delivery Systems‘ Dr. Sarah Molokhia, vice president of research and development, was awarded a...
October 23, 2023 MADRID, Spain — IOT has released the Myopia Management Solution lens in Europe (EU and U.K.), Asia, Latin America,...
September 26, 2023 BERLIN, Germany — Dopavision has successfully completed enrollment for its MyopiaX-1 clinical trial. MyopiaX-1 is a randomized, active-controlled trial...
September 15, 2023 SEATTLE — Kubota Vision and China Medical University Hsinchu Hospital have entered into a collaborative research agreement that will...
June 28, 2023 BERLIN, Germany — Dopavision’s MyopiaX-1 clinical trial centers are now all active, screening and enrolling participants across Germany, Spain,...
March 21, 2023 BERLIN, Germany — Professor Dr. Jens Ellrich has been named the new Chief Scientific Officer at Dopavision, a clinical-stage...
October 17, 2022 By Li Lian Foo, MD, MMed (Ophth), FRCOphth, BEng (1st class honors) With the recent development of several enterprise-grade...
December 16, 2021 DUBLIN, Ireland — Ocuco has invested in Ocumetra, a data science solutions company dedicated to myopia management. As a part...
December 17, 2021 Ocumetra was founded in 2020 by Professor Ian Flitcroft and Professor James Loughman, leaders in the field of myopia...
November 15, 2021 By Hamed Bahmani, BEng, MSc, PhD A smartphone application, MyopiaX is a non-invasive digital treatment designed to achieve a...
October 19, 2021 SEATTLE — Kubota Vision, a subsidiary of Kubota Pharmaceutical Holdings Co., announced that it has received ISO 13485:2016 certification for...
October 15, 2021 By Bala Ambati, MD, PhD, President and Founder, iVeena & Sarah Molokhia, RPh, PhD, VP for Research & Development,...
sponsored content October 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Vyluma is dedicated to using its deep expertise to develop...
September 15, 2021 By Andrei V. Tkatchenko, MD, PhD, and Tatiana V. Tkatchenko, MD The development of effective and safe drugs for...
June 15, 2021 By Ran Yam, Prof. Michael Belkin, MA, MD, Liran Adlin, Nancy LeBosquain The therapeutic principle is similar to the...
April 30, 2021 The Ophthalmology Innovation Summit (OIS) hosted a virtual Myopia Innovation Showcase on Thursday, April 29. The session started with...
April 15, 2021 By Andreas Kelch & Daniel Boss Vivior can offer added value for myopia management by recording the objective visual...
March 15, 2021 By Larry Baitch, OD, PhD, FAAO Arkady Selenow, OD, FAAO, ABO Nabin Joshi, PhD Inna Samandarova, PharmD “This part-time...
March 3, 2021 Rick Gadd, President, Essilor North America, recently met with Review of Myopia Management’s Editor-in-Chief John Sailer to discuss the company’s...
March 3, 2021 Last month, CooperCompanies and EssilorLuxottica announced that they were teaming up to acquire SightGlass Vision. The goal of the joint...
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
October 9, 2020 An ongoing CYPRESS study of Sightglass Vision’s novel eyeglasses designed to slow progression of myopia in children “demonstrated the...
July 22, 2020 Kubota Vision Inc., a clinical-stage ophthalmology company and wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., today announced...